Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

Nabriva is a clinical-stage biopharmaceutical company engaged in the research and development of novel antibiotics to treat serious infections, with a focus on the pleuromutilin class of antibiotics.